SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about presentation

29 Oct 2025 Evaluate
With reference to intimation dated 23rd October 2025, informing about the scheduling of Investor / Analysts Call for update on Un-audited Financial Results for the quarter and nine months ended 30th September 2025 and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that it enclosed presentation that will be made during the call. The presentation is also being uploaded on the Company's website Analyst / Investor Meet.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3587.20 8.65 (0.24%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×